増殖分化因子15(GDF−15)を使用して代謝障害を処置するまたは軽快させる方法
The disclosure relates to the treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), as well as end-stage liver disease, hepatic steatosis (fatty liver), liver fibrosis, liver inflammation, liver cirrhosis, primary biliary cirrhosis (PBC), and hepatocellular...
Saved in:
Format | Patent |
---|---|
Language | Japanese |
Published |
06.10.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!